logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Seres Therapeutics Announces the Appointment of Marella Thorell As Chief Financial Officer and the Retirement of David Arkowitz

Feb 26, 2024•almost 2 years ago

Position

Executive Vice President

Company

Seres Therapeutics

Marella Thorell
CambridgeTherapeuticsBiotechnologyHealth Care

Description

Seres Therapeutics, Inc. announces the appointment of Marella Thorell as Executive Vice President and Chief Financial Officer (CFO), effective March 25th.

Company Information

Company

Seres Therapeutics

Location

Cambridge, Massachusetts, United States

About

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres’ lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months